Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
15 Sep 2020
Historique:
pubmed: 8 8 2020
medline: 6 11 2020
entrez: 8 8 2020
Statut: ppublish

Résumé

There are inconsistencies in concept, criteria, practice, and documentation of brain death/death by neurologic criteria (BD/DNC) both internationally and within countries. To formulate a consensus statement of recommendations on determination of BD/DNC based on review of the literature and expert opinion of a large multidisciplinary, international panel. Relevant international professional societies were recruited to develop recommendations regarding determination of BD/DNC. Literature searches of the Cochrane, Embase, and MEDLINE databases included January 1, 1992, through April 2020 identified pertinent articles for review. Because of the lack of high-quality data from randomized clinical trials or large observational studies, recommendations were formulated based on consensus of contributors and medical societies that represented relevant disciplines, including critical care, neurology, and neurosurgery. Based on review of the literature and consensus from a large multidisciplinary, international panel, minimum clinical criteria needed to determine BD/DNC in various circumstances were developed. Prior to evaluating a patient for BD/DNC, the patient should have an established neurologic diagnosis that can lead to the complete and irreversible loss of all brain function, and conditions that may confound the clinical examination and diseases that may mimic BD/DNC should be excluded. Determination of BD/DNC can be done with a clinical examination that demonstrates coma, brainstem areflexia, and apnea. This is seen when (1) there is no evidence of arousal or awareness to maximal external stimulation, including noxious visual, auditory, and tactile stimulation; (2) pupils are fixed in a midsize or dilated position and are nonreactive to light; (3) corneal, oculocephalic, and oculovestibular reflexes are absent; (4) there is no facial movement to noxious stimulation; (5) the gag reflex is absent to bilateral posterior pharyngeal stimulation; (6) the cough reflex is absent to deep tracheal suctioning; (7) there is no brain-mediated motor response to noxious stimulation of the limbs; and (8) spontaneous respirations are not observed when apnea test targets reach pH <7.30 and Paco2 ≥60 mm Hg. If the clinical examination cannot be completed, ancillary testing may be considered with blood flow studies or electrophysiologic testing. Special consideration is needed for children, for persons receiving extracorporeal membrane oxygenation, and for those receiving therapeutic hypothermia, as well as for factors such as religious, societal, and cultural perspectives; legal requirements; and resource availability. This report provides recommendations for the minimum clinical standards for determination of brain death/death by neurologic criteria in adults and children with clear guidance for various clinical circumstances. The recommendations have widespread international society endorsement and can serve to guide professional societies and countries in the revision or development of protocols and procedures for determination of brain death/death by neurologic criteria, leading to greater consistency within and between countries.

Identifiants

pubmed: 32761206
pii: 2769149
doi: 10.1001/jama.2020.11586
doi:

Types de publication

Consensus Development Conference Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1078-1097

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

David M Greer (DM)

Boston University School of Medicine, Boston, Massachusetts.

Sam D Shemie (SD)

McGill University, Montreal Children's Hospital, Montreal, Canada.
Canadian Blood Services, Ottawa, Canada.

Ariane Lewis (A)

NYU Langone Medical Center, New York, New York.

Sylvia Torrance (S)

Canadian Blood Services, Ottawa, Canada.

Panayiotis Varelas (P)

Albany Medical College, Albany, New York.

Fernando D Goldenberg (FD)

University of Chicago, Chicago, Illinois.

James L Bernat (JL)

Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.

Michael Souter (M)

University of Washington, Seattle.

Mehmet Akif Topcuoglu (MA)

Department of Neurology, Hacettepe University, Ankara, Turkey.

Anne W Alexandrov (AW)

College of Nursing, University of Tennessee Health Science Center, Memphis.

Marie Baldisseri (M)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Thomas Bleck (T)

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Giuseppe Citerio (G)

University Milano-Bicocca, Milano-Bicocca, Italy.

Rosanne Dawson (R)

Canadian Blood Services, Ottawa, Canada.

Arnold Hoppe (A)

Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.

Stephen Jacobe (S)

University of Sydney and Children's Hospital of Westmead, Westmead, Australia.

Alex Manara (A)

Southmead Hospital, Bristol, United Kingdom.

Thomas A Nakagawa (TA)

University of Florida, Jacksonville.

Thaddeus Mason Pope (TM)

Mitchell Hamline School of Law, Saint Paul, Minnesota.

William Silvester (W)

University of Melbourne, Melbourne, Australia.

David Thomson (D)

University of Cape Town, Cape Town, South Africa.

Hussain Al Rahma (H)

Dubai Hospital, Dubai, United Arab Emirates.

Rafael Badenes (R)

Hospital Clinic Universitari, University of Valencia, Valencia, Spain.

Andrew J Baker (AJ)

St. Michael's Hospital, Unity Health Toronto and University of Toronto, Toronto, Canada.

Vladimir Cerny (V)

J.E. Purkinje University, Masaryk Hospital, Usti nad Labem, Czech Republic.

Cherylee Chang (C)

Queen's Medical Center, Honolulu, Hawaii.

Tiffany R Chang (TR)

The University of Texas Health Science Center at Houston, Houston.

Elena Gnedovskaya (E)

Research Center of Neurology, Moscow, Russia.

Moon-Ku Han (MK)

Seoul National University Bundang Hospital, Seoul, Republic of Korea.

Stephen Honeybul (S)

Sir Charles Gairdner Hospital, Nedlands, Australia.

Edgar Jimenez (E)

Texas A&M, College Station.

Yasuhiro Kuroda (Y)

Kagawa University, Kagawa, Japan.

Gang Liu (G)

Capital Medical University, Beijing, China.

Uzzwal Kumar Mallick (UK)

National Institute of Neurosciences and Hospital, Dhaka, Bangladesh.

Victoria Marquevich (V)

Hospital Universitario Austral, Buenos Aires, Argentina.

Jorge Mejia-Mantilla (J)

Fundación Valle del Lili, Cali, Colombia.

Michael Piradov (M)

Research Center of Neurology, Moscow, Russia.

Sarah Quayyum (S)

The University of Toronto, Toronto, Canada.

Gentle Sunder Shrestha (GS)

Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Ying-Ying Su (YY)

Capital Medical University, Beijing, China.

Shelly D Timmons (SD)

Indiana University, Indianapolis.

Jeanne Teitelbaum (J)

Montreal Neurological Institute, Montreal, Canada.

Walter Videtta (W)

National Hospital, Alejandro Posadas, Buenos Aires, Argentina.

Kapil Zirpe (K)

Ruby Hall Clinic, Pune, India.

Gene Sung (G)

University of Southern California, Los Angeles.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH